U.S. Markets open in 2 hrs 51 mins

Novartis Missed Revenue Estimates in Q3 2018

Mike Benson
Novartis Missed Revenue Estimates in Q3 2018

Novartis (NVS) released its third-quarter earnings results on October 18. The company surpassed Wall Street analysts’ consensus estimate for EPS but missed their estimate for revenue in the quarter. Novartis reported EPS of $1.32 on revenue of ~$12.78 billion compared to analysts’ estimate of EPS of $1.31 on revenue of ~$13.02 billion.